BACKBLAZE INC-A (BLZE)

US05637B1052 - Common Stock

6.72  +0.23 (+3.54%)

Premarket: 6.5785 -0.14 (-2.11%)

Fundamental Rating

2

BLZE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the IT Services industry. BLZE has a bad profitability rating. Also its financial health evaluation is rather negative. BLZE is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

BLZE had negative earnings in the past year.
BLZE had a positive operating cash flow in the past year.
In the past 5 years BLZE always reported negative net income.
In multiple years BLZE reported negative operating cash flow during the last 5 years.

1.2 Ratios

BLZE has a worse Return On Assets (-34.03%) than 83.95% of its industry peers.
BLZE has a Return On Equity of -108.24%. This is amonst the worse of the industry: BLZE underperforms 81.48% of its industry peers.
Industry RankSector Rank
ROA -34.03%
ROE -108.24%
ROIC N/A
ROA(3y)-30.77%
ROA(5y)-21.41%
ROE(3y)-76.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BLZE's Gross Margin of 53.78% is fine compared to the rest of the industry. BLZE outperforms 75.31% of its industry peers.
In the last couple of years the Gross Margin of BLZE has declined.
The Profit Margin and Operating Margin are not available for BLZE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.06%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

BLZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BLZE has more shares outstanding
BLZE has a worse debt/assets ratio than last year.

2.2 Solvency

BLZE has an Altman-Z score of -0.35. This is a bad value and indicates that BLZE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.35, BLZE is doing worse than 82.72% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that BLZE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.39, BLZE is in line with its industry, outperforming 51.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z -0.35
ROIC/WACCN/A
WACC11.6%

2.3 Liquidity

A Current Ratio of 0.54 indicates that BLZE may have some problems paying its short term obligations.
BLZE has a Current ratio of 0.54. This is amonst the worse of the industry: BLZE underperforms 91.36% of its industry peers.
A Quick Ratio of 0.54 indicates that BLZE may have some problems paying its short term obligations.
The Quick ratio of BLZE (0.54) is worse than 91.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.56% over the past year.
Looking at the last year, BLZE shows a very strong growth in Revenue. The Revenue has grown by 27.41%.
Measured over the past years, BLZE shows a very strong growth in Revenue. The Revenue has been growing by 23.79% on average per year.
EPS 1Y (TTM)45.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.09%
Revenue 1Y (TTM)27.41%
Revenue growth 3Y23.79%
Revenue growth 5YN/A
Sales Q2Q%28.82%

3.2 Future

The Earnings Per Share is expected to grow by 22.73% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 20.16% on average over the next years. This is a very strong growth
EPS Next Y38.71%
EPS Next 2Y22.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.72%
Revenue Next 2Y20.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLZE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLZE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BLZE's earnings are expected to grow with 22.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.73%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BLZE!.
Industry RankSector Rank
Dividend Yield N/A

BACKBLAZE INC-A

NASDAQ:BLZE (12/2/2024, 8:26:35 PM)

Premarket: 6.5785 -0.14 (-2.11%)

6.72

+0.23 (+3.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap298.37M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.03%
ROE -108.24%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 53.78%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)45.56%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y38.71%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.41%
Revenue growth 3Y23.79%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y